These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29581598)

  • 1. Formulary Drug Reviews: Glecaprevir/Pibrentasvir.
    Levien TL; Baker DE
    Hosp Pharm; 2018 Apr; 53(2):75-84. PubMed ID: 29581598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulary Drug Review: Etelcalcetide.
    Baker DE
    Hosp Pharm; 2017 Nov; 52(10):669-674. PubMed ID: 29276237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulary Drug Reviews: Nirsevimab.
    Levien TL; Baker DE
    Hosp Pharm; 2024 Apr; 59(2):138-145. PubMed ID: 38450347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulary Drug Review: Ocrelizumab.
    Ali ZK; Baker DE
    Hosp Pharm; 2017 Oct; 52(9):599-606. PubMed ID: 29276296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary Drug Review: Edaravone.
    Ali ZK; Baker DE
    Hosp Pharm; 2017 Dec; 52(11):732-736. PubMed ID: 29276251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary Drug Review: Odevixibat.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Apr; 58(2):125-133. PubMed ID: 36890950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulary Drug Review: Belumosudil.
    Levien TL; Baker DE
    Hosp Pharm; 2022 Aug; 57(4):435-441. PubMed ID: 35898245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary Drug Reviews: Brexanolone Injection.
    Levien TL; Baker DE
    Hosp Pharm; 2022 Oct; 57(5):615-621. PubMed ID: 36081541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary Drug Review: Sufentanil Sublingual.
    Baker DE
    Hosp Pharm; 2019 Aug; 54(4):222-228. PubMed ID: 31320770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary Drug Review: Naldemedine.
    Baker DE
    Hosp Pharm; 2017 Jul; 52(7):464-468. PubMed ID: 29276274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levoketoconazole.
    McCartney NK; Baker DE
    Hosp Pharm; 2022 Oct; 57(5):605-614. PubMed ID: 36081533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulary Drug Review: Betrixaban.
    Baker DE
    Hosp Pharm; 2018 Feb; 53(1):29-37. PubMed ID: 29434384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vericiguat.
    Nguyen L; Baker DE
    Hosp Pharm; 2023 Oct; 58(5):431-436. PubMed ID: 37711406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crizanlizumab.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Feb; 58(1):23-29. PubMed ID: 36644753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II.
    Baker DE; Levien TL
    Hosp Pharm; 2018 Jul; 53(4):230-233. PubMed ID: 30038440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Oct; 58(5):420-430. PubMed ID: 37711410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omadacycline.
    Baker DE
    Hosp Pharm; 2019 Apr; 54(2):80-87. PubMed ID: 30923399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirzepatide.
    Baker DE; Walley K; Levien TL
    Hosp Pharm; 2023 Jun; 58(3):227-243. PubMed ID: 37216078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maribavir.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Aug; 58(4):336-344. PubMed ID: 37360201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Zirconium Cyclosilicate.
    Levien TL; Baker DE
    Hosp Pharm; 2019 Feb; 54(1):12-19. PubMed ID: 30718929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.